![](https://cdn.sanity.io/images/0vv8moc6/onclive/88e5bec90aac2c72df644ffd9ba00ba6dccfce8a-200x200.png?fit=crop&auto=format)
340B Drug Pricing Program Ostensibly Improves Cancer Care but Carries Unforeseen Consequences
Since its inception, the 340B Drug Pricing Program has aimed to improve access to affordable medications for patients with cancer and other diseases. Although the program has been largely successful in some areas, there are other aspects of its current …